 Genesco Inc NYSE: GCO reported second-quarter FY22 sales growth of 42 year-on-year, to 555.18 million, beating the analyst consensus of 517.76 million. Comparable direct sales were down 23, compared to up 144 for Q2 FY21 and up 20 versus Q2 FY20. 